Post Profile






New York accuses Insys of deceptively marketing opioid

(Reuters) - New York's attorney general on Thursday filed a lawsuit against Insys Therapeutics Inc seeking $75 million from the pharmaceutical company, which he said deceptively promoted a powerful fentanyl-based cancer pain medicine for unsafe uses.
read more

share

Related Posts


Arizona accuses drugmaker Insys of fraudulent opioid marketing

Health : Reuters: Health

(Reuters) - Arizona sued Insys Therapeutics Inc on Thursday, accusing the drugmaker of engaging in a fraudulent marketing scheme aimed at increasing sales of a fentanyl-based cancer pain medicine called Subsys.

North Carolina sues drugmaker Insys over role in opioid epidemic

Health : Reuters: Health

(Reuters) - North Carolina on Thursday sued Insys Therapeutics Inc over its role in the opioid epidemic, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys in a ques...

Insys agrees to pay $4.45 million to resolve Illinois opioid lawsuit

Health : Reuters: Health

BOSTON (Reuters) - Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.

North Carolina accuses drugmaker Insys of scheme to push opioid

Health : Reuters: Health

BOSTON (Reuters) - North Carolina sued Insys Therapeutics Inc on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid e...

Maryland sues Insys to enforce subpoena in opioid probe

Health : Reuters: Health

(Reuters) - Maryland's attorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of an investigation into allegations the drugmaker deceptively marketed a fentanyl-based cancer ...

Comments


Copyright © 2016 Regator, LLC